BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38518977)

  • 1. Non-sclerosing (T-cell) and sclerosing (B-cell) lymphocytic lobulitis in diagnostic breast biopsies: Clinical, imaging, and pathologic features.
    Ngo MH; Pinkus GS; Yeh ED; Brock JE; Schulte S; Lester SC
    Hum Pathol; 2024 Apr; 146():28-34. PubMed ID: 38518977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes.
    Kudva YC; Reynolds C; O'Brien T; Powell C; Oberg AL; Crotty TB
    Diabetes Care; 2002 Jan; 25(1):121-6. PubMed ID: 11772912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound as a Valuable Imaging Modality in Sclerosing Lymphocytic Lobulitis: Imaging Features Based on a Retrospective Cohort Analysis of 51 Cases.
    Sato LT; de Mello GGN; Stiepcich MMA; Tucunduva TCM; Torres US; Reis AF; Lederman HM
    Can Assoc Radiol J; 2021 Nov; 72(4):767-774. PubMed ID: 33461324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screen detected sclerosing lymphocytic lobulitis and amyloid of the breast in the same patient--a possible causal link.
    Turner CA; Rubin CM; Royle GT; Flynn M; Theaker JM
    Breast; 2006 Apr; 15(2):281-3. PubMed ID: 15982886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerosing lymphocytic lobulitis in the male breast.
    Lee AH; Zafrani B; Kafiri G; Rozan S; Millis RR
    J Clin Pathol; 1996 Jul; 49(7):609-11. PubMed ID: 8813969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Sclerosing Lymphocytic Lobulitis of the Breast Associated with Diabetes Mellitus.
    Inoue S; Mogaki M; Kato J; Takazawa T; Natori H; Matsukawa T; Kunitomo K; Fujii H; Sekikawa T; Matsumoto Y
    Breast Cancer; 1998 Jul; 5(3):313-316. PubMed ID: 11091663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte subsets contribute to the degree of lobulitis and ductitis in sclerosing lymphocytic lobulitis of the breast.
    Chen LY; Tsang JY; Ni YB; Chan SK; Chan KF; Zhang S; Tse GM
    J Clin Pathol; 2016 Jun; 69(6):527-32. PubMed ID: 26582743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and therapeutic management of diabetic mastopathy: a case report.
    Cirrito D; Orlando AA; Narese F; Narese D; Curatolo C; Midiri F; Virzì G; Virzì V
    Clin Ter; 2015; 166(3):e169-72. PubMed ID: 26152627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerosing lymphocytic lobulitis in the absence of diabetes or autoimmune disease: radiological findings.
    Oztekin PS; Karatas B; Ugur S; Kosar PN; Erel S; Borcek P
    Breast J; 2014; 20(6):655-7. PubMed ID: 25252167
    [No Abstract]   [Full Text] [Related]  

  • 10. Sclerosing lymphocytic lobulitis in a male patient with asthma.
    Batrani M; Bhardwaj M; Biswal UC
    Breast Dis; 2011; 33(3):143-7. PubMed ID: 22571937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.
    Shimada S; Yoshida R; Nakashima E; Kitagawa D; Gomi N; Horii R; Takeuchi S; Ashihara Y; Kita M; Akiyama F; Ohno S; Saito M; Arai M
    Breast Cancer; 2019 Nov; 26(6):846-851. PubMed ID: 30980249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mastopathy and diabetes.
    Kudva YC; Reynolds CA; O'Brien T; Crotty TB
    Curr Diab Rep; 2003 Feb; 3(1):56-9. PubMed ID: 12643147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography.
    van Zelst JCM; Mus RDM; Woldringh G; Rutten MJCM; Bult P; Vreemann S; de Jong M; Karssemeijer N; Hoogerbrugge N; Mann RM
    Radiology; 2017 Nov; 285(2):376-388. PubMed ID: 28609204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine needle aspiration of sclerosing lymphocytic lobulitis of the breast. A report of two cases.
    Miralles TG; Gosalbez F; Menendez P; Manjon JA; Sampedro A
    Acta Cytol; 1998; 42(6):1447-50. PubMed ID: 9850659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
    Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
    Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoepithelioma-like carcinoma of the breast with associated sclerosing lymphocytic lobulitis.
    Naidoo P; Chetty R
    Arch Pathol Lab Med; 2001 May; 125(5):669-72. PubMed ID: 11300942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal Findings Detected by Multi-modality Breast Imaging and Biopsy Results in a High-risk Clinic.
    Laitman Y; Feldman DM; Sklair-Levy M; Yosepovich A; Barshack-Nakar I; Brodsky M; Halshtok O; Shalmon A; Gotlieb M; Friedman E
    Clin Breast Cancer; 2018 Aug; 18(4):e695-e698. PubMed ID: 29292184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerosing lymphocytic lobulitis of the breast.
    Williams PH; Rubin CM; Theaker JM
    Clin Radiol; 1995 Mar; 50(3):165-7. PubMed ID: 7889706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of perforin and tumour necrosis factor alpha mRNA expressing cells in sclerosing lymphocytic lobulitis of the breast.
    Hunger RE; Hristic M; Mueller C; Kappeler A; Altermatt HJ
    J Clin Pathol; 1997 Apr; 50(4):310-3. PubMed ID: 9215147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer.
    Griebsch I; Brown J; Boggis C; Dixon A; Dixon M; Easton D; Eeles R; Evans DG; Gilbert FJ; Hawnaur J; Kessar P; Lakhani SR; Moss SM; Nerurkar A; Padhani AR; Pointon LJ; Potterton J; Thompson D; Turnbull LW; Walker LG; Warren R; Leach MO;
    Br J Cancer; 2006 Oct; 95(7):801-10. PubMed ID: 17016484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.